Technical Analysis for KPTI - Karyopharm Therapeutics Inc.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| See historical KPTI trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Jan 18 | 20 DMA Support | Bullish | 0.00% |
| Jan 17 | Spinning Top | Other | 1.54% |
| Jan 16 | 50 DMA Resistance | Bearish | 0.20% |
| Jan 16 | 180 Bearish Setup | Bearish Swing Setup | 0.20% |
| Jan 16 | Multiple of Ten Bearish | Other | 0.20% |
| Jan 15 | 20 DMA Support | Bullish | -0.70% |
| Jan 14 | 180 Bearish Setup | Bearish Swing Setup | 1.75% |
| Jan 14 | Multiple of Ten Bearish | Other | 1.75% |
| Jan 14 | Overbought Stochastic | Strength | 1.75% |
| Jan 14 | Down 3 Days in a Row | Weakness | 1.75% |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 2018-11-08
- Sector: Healthcare
- Industry: Bio Therapeutic Drugs
Karyopharm Therapeutics Inc., a clinical-stage pharmaceutical company, focuses on the discovery and development of drugs directed against nuclear transport targets for the treatment of cancer and other major diseases. The company's lead drug candidate includes Selinexor, an oral selective inhibitors of nuclear export (SINE) compound that specifically blocks XPO1 cargo binding is in Phase I clinical trials in patients with heavily pretreated relapsed and/or refractory hematological and solid tumor malignancies. Its other drug candidates comprise KPT-350 and related SINE compounds; PAK4 inhibitors; and Verdinexor, a SINE compound that is in Phase IIb clinical trials in pet dogs with newly-diagnosed or first relapse after chemotherapy lymphomas. The company was founded in 2008 and is based in Natick, Massachusetts.
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more KPTI news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 21.71 |
| 52 Week Low | 8.01 |
| Average Volume | 591,226 |
| 200-Day Moving Average | 15.075 |
| 50-Day Moving Average | 10.0874 |
| 20-Day Moving Average | 9.561 |
| 10-Day Moving Average | 10.0 |
| Average True Range | 0.5465 |
| ADX | 14.48 |
| +DI | 17.7945 |
| -DI | 22.6964 |
| Chandelier Exit (Long, 3 ATRs ) | 8.8955 |
| Chandelier Exit (Short, 3 ATRs ) | 9.6495 |
| Upper Bollinger Band | 10.7534 |
| Lower Bollinger Band | 8.3686 |
| Percent B (%b) | 0.63 |
| BandWidth | 24.942998 |
| MACD Line | -0.0334 |
| MACD Signal Line | -0.0988 |
| MACD Histogram | 0.0653 |
| Fundamentals | Value |
|---|---|
| Market Cap | 464.78 Million |
| Num Shares | 47.1 Million |
| EPS | -2.69 |
| Price-to-Earnings (P/E) Ratio | -3.67 |
| Price-to-Sales | 2836.82 |
| Price-to-Book | 2.82 |
| PEG Ratio | -0.13 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 10.34 | ||||
| Resistance 3 (R3) | 10.29 | 10.08 | 10.26 | ||
| Resistance 2 (R2) | 10.08 | 9.96 | 10.11 | 10.23 | |
| Resistance 1 (R1) | 9.97 | 9.88 | 10.03 | 10.02 | 10.21 |
| Pivot Point | 9.76 | 9.76 | 9.79 | 9.79 | 9.76 |
| Support 1 (S1) | 9.65 | 9.64 | 9.71 | 9.70 | 9.51 |
| Support 2 (S2) | 9.44 | 9.56 | 9.47 | 9.49 | |
| Support 3 (S3) | 9.33 | 9.44 | 9.46 | ||
| Support 4 (S4) | 9.38 |
